Stroke Impact Scale
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (31/10/2023)
Original Editor - User Name
Top Contributors - Carina Therese Magtibay
Objective[edit | edit source]
The Stroke Impact Scale (SIS) is a patient-reported outcome measure that evaluates the biopsychosocial aspects of life after stroke. [1] It is designed by Duncan et al at the University of Kansas Medical Center in 1999, first published as version 2.0.[2] The original 64-item tool was shortened to be 58-item after a Rasch analysis process, creating the current version 3.0.[3]
Intended Population[edit | edit source]
The tool is intended for post-stroke patients.
Method of Use[edit | edit source]
Equipment required: Questionnaire and pen
Time to administer: 15-20 minutes
Instructions: Rate the level of difficulty of completing an item in the past 2 weeks following a 5-point Likert scale:
- 1 = could not do it at all
- 2= very difficult
- 3= somewhat difficult
- 4= a little difficult
- 5= not difficult at all
Domains:
The questionnaire consists of 59 items that assess 8 domains:
- Strength (4 items)
- Hand function (5 items)
- ADL/IADL (10 items)
- Mobility (9 items)
- Communication (7 items)
- Emotion (9 items)
- Memory and thinking (7 items)
- Participation/Role function (8 items)
Scoring:
Summative scores are generated for each domain, scores ranging from 0-100.
Formula for each scale:
Transformed Scale = [(Actual raw score - lowest possible raw score) / Possible raw score range] x 100
Evidence[edit | edit source]
Reliability[edit | edit source]
Validity[edit | edit source]
Responsiveness[edit | edit source]
Miscellaneous
[edit | edit source]
Links[edit | edit source]
Stroke Impact Scale version 3.0
References[edit | edit source]
- ↑ Mulder M, Nijland R. Stroke impact scale. Journal of physiotherapy. 2016;2(62):117.
- ↑ Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ. The stroke impact scale version 2.0: evaluation of reliability, validity, and sensitivity to change. Stroke. 1999 Oct;30(10):2131-40.
- ↑ Duncan PW, Bode RK, Lai SM, Perera S, Glycine Antagonist in Neuroprotection Americas Investigators. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Archives of physical medicine and rehabilitation. 2003 Jul 1;84(7):950-63. BibTeXEndNoteRefManRefWorks
